Design Therapeutics (DSGN) Stock Chart & Stock Price History $4.32 +0.35 (+8.69%) As of 03:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Design Therapeutics Stock Price Performance The Design Therapeutics (DSGN) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 6.28%, with a year-to-date return of -30.06%. In the past month, the stock has increased 18.54%, reflecting recent market activity. As of the latest close, Design Therapeutics traded at $3.97 with a market cap of $225.38 million and volume of 61,872 shares. Receive DSGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Design Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+12.96%1 Month Performance+18.54%3 Month Performance+22.59%Year-To-Date Performance-30.06%1 Year Performance+6.28% DSGN Stock Chart for Friday, August, 8, 2025 DSGN Chart by TradingView Design Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/07/2025$4.35$3.97-8.74%$4.35$3.9561,872 shs$225.38 million08/06/2025$4.06$4.35+7.14%$4.42$3.9662,946 shs$246.95 million08/05/2025$3.96$4.06+2.53%$4.13$3.9077,760 shs$230.49 million08/04/2025$3.82$3.96+3.66%$4.13$3.85117,355 shs$224.81 million08/01/2025$3.87$3.82-1.29%$3.92$3.7762,810 shs$216.86 million07/31/2025$4.03$3.87-3.97%$4.10$3.76164,056 shs$219.70 million07/30/2025$3.98$4.03+1.26%$4.19$3.9864,598 shs$228.78 million07/29/2025$4.04$3.98-1.49%$4.10$3.89166,230 shs$225.94 million07/28/2025$4.02$4.04+0.50%$4.16$3.9542,347 shs$229.35 million07/25/2025$4.04$4.02-0.50%$4.16$3.8554,081 shs$228.22 million Get the Latest News and Ratings for DSGN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Design Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/24/2025$4.27$4.04-5.39%$4.32$4.0453,942 shs$229.35 million07/23/2025$4.25$4.27+0.47%$4.44$4.2452,482 shs$242.40 million07/22/2025$4.05$4.25+4.94%$4.26$4.0447,486 shs$241.27 million07/21/2025$3.98$4.05+1.76%$4.11$3.9978,017 shs$229.92 million07/18/2025$4.02$3.98-1.00%$4.07$3.9567,769 shs$225.95 million07/17/2025$4.15$4.02-3.13%$4.34$3.9590,613 shs$228.21 million07/16/2025$3.92$4.15+5.87%$4.21$3.9675,620 shs$235.60 million07/15/2025$4.00$3.92-2.00%$3.99$3.9190,542 shs$222.53 million07/14/2025$3.92$4.00+2.04%$4.10$3.8445,034 shs$227.08 million07/11/2025$4.04$3.92-2.97%$4.09$3.8655,272 shs$222.54 million07/10/2025$4.17$4.04-3.12%$4.15$3.9565,012 shs$229.35 million07/09/2025$3.64$4.17+14.56%$4.21$3.59248,717 shs$236.73 million07/08/2025$3.54$3.64+2.82%$3.74$3.52154,453 shs$206.64 million07/07/2025$3.77$3.54-6.10%$3.81$3.54236,098 shs$200.96 million Related Companies LENZ Stock Price Chart TRVI Stock Price Chart SNDX Stock Price Chart URGN Stock Price Chart NUVB Stock Price Chart SION Stock Price Chart MRSN Stock Price Chart PROK Stock Price Chart CRMD Stock Price Chart XERS Stock Price Chart Receive DSGN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Design Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:DSGN) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredGold Hit $3,500. Here’s What’s Next…Gold just smashed through $3,500—and some experts believe that’s only the beginning. With big banks like Goldm...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Design Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Design Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DSGN Stock Alerts